Lucid Diagnostics Files 8-K: Material Agreement & Financials
Ticker: LUCD · Form: 8-K · Filed: Apr 10, 2025 · CIK: 1799011
Sentiment: neutral
Topics: material-agreement, financials
TL;DR
Lucid Diagnostics filed an 8-K on 4/10 for an April 9th event, including a material agreement and financials.
AI Summary
Lucid Diagnostics Inc. filed an 8-K on April 10, 2025, reporting on events that occurred on April 9, 2025. The filing indicates the company entered into a material definitive agreement and also includes Regulation FD disclosures and financial statements/exhibits. Specific details of the agreement and financial figures are not provided in this excerpt.
Why It Matters
This 8-K filing signals a significant event for Lucid Diagnostics, potentially involving a new contract or partnership, and provides updated financial information that could impact investor decisions.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could be positive or negative depending on its terms, and the inclusion of financial statements suggests potential changes in the company's financial health.
Key Players & Entities
- Lucid Diagnostics Inc. (company) — Registrant
- April 9, 2025 (date) — Date of earliest event reported
- April 10, 2025 (date) — Date of report
- 360 Madison Avenue, 25th Floor, New York, NY 10017 (address) — Principal Executive Offices
FAQ
What is the nature of the material definitive agreement entered into by Lucid Diagnostics?
The provided excerpt does not specify the details of the material definitive agreement.
When did the events reported in the 8-K filing occur?
The earliest event reported occurred on April 9, 2025.
What is the principal executive office address for Lucid Diagnostics?
The principal executive office is located at 360 Madison Avenue, 25th Floor, New York, NY 10017.
What is the SEC file number for Lucid Diagnostics?
The SEC file number for Lucid Diagnostics is 001-40901.
What items are covered in this 8-K filing?
This 8-K filing covers entry into a material definitive agreement, Regulation FD disclosure, and financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 10, 2025 regarding Lucid Diagnostics Inc. (LUCD).